TUBERCULOSIS, PULMONARY
Clinical trials for TUBERCULOSIS, PULMONARY explained in plain language.
Never miss a new study
Get alerted when new TUBERCULOSIS, PULMONARY trials appear
Sign up with your email to follow new studies for TUBERCULOSIS, PULMONARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Researchers test supercharged TB drug dose in major safety trial
Disease control Recruiting nowThis study is testing if a much higher daily dose of the tuberculosis drug rifampicin is safe and works better than the standard dose. It will involve 164 adults with lung TB, checking for liver damage and other side effects while seeing if patients recover faster. The goal is to…
Matched conditions: TUBERCULOSIS, PULMONARY
Phase: PHASE3 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Could a 2-Month treatment cure Kids' TB?
Disease control Recruiting nowThis study is testing if a shorter, 2-month treatment plan can cure drug-susceptible tuberculosis (TB) in children as well as the current standard 4-6 month plan. It will enroll 860 children under 10 years old to compare the safety and effectiveness of the two regimens. The goal …
Matched conditions: TUBERCULOSIS, PULMONARY
Phase: PHASE3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Computer models aim to Fine-Tune TB drug doses for better results
Disease control Recruiting nowThis study is testing a new approach to personalize tuberculosis (TB) treatment. It aims to see if using computer models can help doctors adjust a patient's drug doses more quickly and accurately during the early phase of treatment. The goal is to ensure patients get the right am…
Matched conditions: TUBERCULOSIS, PULMONARY
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Breakthrough trial aims to slash TB treatment time in half
Disease control Recruiting nowThis international trial is testing whether shorter antibiotic regimens (13-24 weeks) can work as well as the current standard 24-week treatment for drug-resistant tuberculosis. Researchers will enroll 400 participants with specific drug-resistant TB strains to compare different …
Matched conditions: TUBERCULOSIS, PULMONARY
Phase: PHASE2, PHASE3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC
-
Massive study tests best way to stop TB before it spreads
Prevention Recruiting nowThis five-year study in Uganda is testing two different strategies to find people with tuberculosis (TB) and connect them to treatment or preventive medicine. One approach works from health clinics, while the other targets specific high-risk neighborhoods. The goal is to see whic…
Matched conditions: TUBERCULOSIS, PULMONARY
Phase: NA • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Mar 30, 2026 14:27 UTC
-
Ear pins tested to stop TB drug sickness
Symptom relief Recruiting nowThis study is testing whether small, press-in needles placed on the ear can safely reduce nausea and vomiting caused by tuberculosis medications. Researchers will compare real ear acupuncture to a fake version in 58 patients experiencing these side effects. The goal is to find a …
Matched conditions: TUBERCULOSIS, PULMONARY
Phase: NA • Sponsor: Indonesia University • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC